Dr. Robert Yeh is an associate in the San Diego office of Latham & Watkins and is a member of the firm’s Corporate Department and Healthcare & Life Sciences Practice.
Robert advises companies and their investors in the life sciences space on intellectual property issues that are essential to their success at all stages of their life cycle, drawing on his extensive experience as a scientist and former patent litigator. Robert advises clients on matters including:
Robert also represents various, buyers, sellers, investment banks, and other financial institutions in performing intellectual property due diligence for private and public financings and mergers and acquisitions.
Robert is registered to practice before the United States Patent and Trademark Office. Prior to joining Latham, Robert developed substantial experience in patent litigation and patent prosecution and counselling. He has represented multinational and start-up companies in patent litigation in pharmaceutical, life sciences, among other areas.
Robert earned a PhD at UC Berkeley in chemistry for his work in Dr. Kenneth Raymond’s laboratory on supramolecular nano-cages. Robert held a postdoctoral research position at The Scripps Research Institute and was a research scientist at a multinational medical diagnostics company, focusing on bioconjugation and macromolecular therapeutics and imaging agents (MRI and PET).
While in law school, he received the American Jurisprudence prize in Intellectual Property Strategy and in Partnership & LLC. He is a named co-inventor on a US patent and is a co-author of 10 peer-reviewed research publications.
Robert's representative transactions include:
*Matters handled prior to joining Latham
Latham honored for securing a US$10.75 million damages verdict for client Philip Morris International in a patent infringement trial over vaping technology against R.J. Reynolds Vapor.
Chambers USA recognized the firm’s Mergers & Acquisitions Practice for “world class expertise when it comes to the most challenging transactions.”